Moderna, Inc. (MRNA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: $66.73M2017: -$331.48M2018: -$330.87M2019: -$459.00M2020: $2.03B2021: $13.62B2022: $4.98B2023: -$3.12B2024: -$3.00B2025: -$1.87B-$1.87B
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$1.87B+37.6%
2024-$3.00B+3.7%
2023-$3.12B-162.6%
2022$4.98B-63.4%
2021$13.62B+571.9%
2020$2.03B+541.6%
2019-$459.00M-38.7%
2018-$330.87M+0.2%
2017-$331.48M-596.7%
2016$66.73M